On reporting results from randomized controlled trials with recurrent events.
about
Alternative statistical methods for estimating efficacy of interferon beta-1b for multiple sclerosis clinical trials.Evaluating interventions to promote routine preventive screenings: a comparison of analytical outcomes.Incomparable Subsequent Effects between Study and Control Fluids Might Cause Questionable Results in Randomized Controlled Trials.Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickl
P2860
On reporting results from randomized controlled trials with recurrent events.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
On reporting results from randomized controlled trials with recurrent events.
@ast
On reporting results from randomized controlled trials with recurrent events.
@en
On reporting results from randomized controlled trials with recurrent events.
@nl
type
label
On reporting results from randomized controlled trials with recurrent events.
@ast
On reporting results from randomized controlled trials with recurrent events.
@en
On reporting results from randomized controlled trials with recurrent events.
@nl
prefLabel
On reporting results from randomized controlled trials with recurrent events.
@ast
On reporting results from randomized controlled trials with recurrent events.
@en
On reporting results from randomized controlled trials with recurrent events.
@nl
P2093
P2860
P356
P1476
On reporting results from randomized controlled trials with recurrent events.
@en
P2093
Boris G Sobolev
Lisa Kuramoto
Meghan G Donaldson
P2860
P2888
P356
10.1186/1471-2288-8-35
P577
2008-05-30T00:00:00Z
P5875
P6179
1049803342